title: New approaches to treatment of chronic viral hepatitis.
abstract: Despite rapid progress in knowledge of the biology of hepatitis viruses, the ability to treat chronic infection is limited. In fact, interferon-alpha 2b is the only FDA-approved therapy for chronic HBV and chronic HCV. The authors report on the interferons and evolving therapies for chronic viral hepatitis and conclude with a discussion of liver transplantation.
authors.affiliation: Department of Medicine, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA.
authors.forename: C C
authors.initials: CC
authors.lastname: Holland
authors.forename: T L
authors.initials: TL
authors.lastname: Wright
mesh_terms: D002908:Chronic Disease; D006525:Hepatitis, Viral, Human / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D016031:Liver Transplantation
chemical_list: D007372:Interferons